Concluding remarks and future directions.
Servicio de Hematología. Hospital Universitario de Salamanca, CIC, IBMCC (USAL-CSIC), Spain. sanmigiz@usal.es
Jesús F
JF
San-Miguel
D016588:Anticarcinogenic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use*; D005544:Forecasting; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000188:drug therapy; D057285:Precision Medicine / Q000639:trends; D011379:Prognosis
D016588:Anticarcinogenic Agents; D007155:Immunologic Factors